Cite
HARVARD Citation
Marty, F. et al. (2020). Outcomes of patients with detectable CMV DNA at randomization in the phase III trial of letermovir for the prevention of CMV infection in allogeneic hematopoietic cell transplantation. American journal of transplantation. 20 (6), pp. 1703-1711. [Online].